Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ximo Pechuan-Jorge

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Microbiology|November 8, 2021
Emerging Adaptive Strategies Under Temperature Fluctuations in a Laboratory Evolution Experiment of <i>Escherichia Coli</i>Maryl Lambros, Ximo Pechuan-Jorge, Daniel Biro, et al.
Molecular Cancer Research : MCR|March 17, 2022
Origins and Timing of Emerging Lesions in Advanced Renal Cell CarcinomaAndrew Wallace, Sima P Porten, Amy A Lo, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapiesAmy A Lo, Andrew Wallace, Daniel Oreper, et al.
The Journal of Experimental Medicine|July 23, 2021
ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responsesAnna-Maria Herzner, Zia Khan, Eric L Van Nostrand, et al.
Cancer Immunology Research|November 4, 2025
RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant MelanomaLarissa Anastacio Da Costa Carvalho, Nataliya Tovbis Shifrin, Manali S Phadke, et al.
Cancer Discovery|April 29, 2025
A RAS(ON) multi-selective inhibitor combination therapy triggers long-term tumor control through senescence-associated tumor-immune equilibrium in PDACCaroline Broderick, Riccardo Mezzadra, Exequiel M Sisso, et al.
Plos Biology|April 10, 2025
A nonenzymatic dependency on inositol-requiring enzyme 1 controls cancer cell cycle progression and tumor growthIratxe Zuazo-Gaztelu, David Lawrence, Ioanna Oikonomidi, et al.
Gigascience|August 29, 2025
SPEX: A modular end-to-end platform for high-plex tissue spatial omics analysisXiao Li, Ximo Pechuan-Jorge, Tyler Risom, et al.
Blood Advances|November 18, 2022
Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral loadDevon J Eddins, Junkai Yang, Astrid Kosters, et al.
Nature Immunology|March 22, 2022
Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunityRosa Barreira da Silva, Ricardo M Leitao, Ximo Pechuan-Jorge, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Microbiology|November 8, 2021
Emerging Adaptive Strategies Under Temperature Fluctuations in a Laboratory Evolution Experiment of <i>Escherichia Coli</i>Maryl Lambros, Ximo Pechuan-Jorge, Daniel Biro, et al.
Molecular Cancer Research : MCR|March 17, 2022
Origins and Timing of Emerging Lesions in Advanced Renal Cell CarcinomaAndrew Wallace, Sima P Porten, Amy A Lo, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapiesAmy A Lo, Andrew Wallace, Daniel Oreper, et al.
The Journal of Experimental Medicine|July 23, 2021
ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responsesAnna-Maria Herzner, Zia Khan, Eric L Van Nostrand, et al.
Cancer Immunology Research|November 4, 2025
RAS(ON) Multiselective Inhibition Drives Antitumor Immunity in Preclinical Models of NRAS-Mutant MelanomaLarissa Anastacio Da Costa Carvalho, Nataliya Tovbis Shifrin, Manali S Phadke, et al.
Cancer Discovery|April 29, 2025
A RAS(ON) multi-selective inhibitor combination therapy triggers long-term tumor control through senescence-associated tumor-immune equilibrium in PDACCaroline Broderick, Riccardo Mezzadra, Exequiel M Sisso, et al.
Plos Biology|April 10, 2025
A nonenzymatic dependency on inositol-requiring enzyme 1 controls cancer cell cycle progression and tumor growthIratxe Zuazo-Gaztelu, David Lawrence, Ioanna Oikonomidi, et al.
Gigascience|August 29, 2025
SPEX: A modular end-to-end platform for high-plex tissue spatial omics analysisXiao Li, Ximo Pechuan-Jorge, Tyler Risom, et al.
Blood Advances|November 18, 2022
Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral loadDevon J Eddins, Junkai Yang, Astrid Kosters, et al.
Nature Immunology|March 22, 2022
Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunityRosa Barreira da Silva, Ricardo M Leitao, Ximo Pechuan-Jorge, et al.
Pageof 2